[1. The World Health Organization (WHO) updates fact sheet on Top 10 causes of Death, https://communitymedicine4asses.wordpress.com/2017/02/01/who-updates-fact-sheet-on-top-10-causes-of-death-27-january-2017]Search in Google Scholar
[2. Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA – Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 2014; 383(9913):245-25410.1016/S0140-6736(13)61953-4]Search in Google Scholar
[3. Alves JE, Carneiro A, Xavier J –Reliability of CT perfusion in the evaluation of the ischaemic penumbra. Neuroradiol J 2014; 27(1):91-9510.15274/NRJ-2014-10010420284924571838]Search in Google Scholar
[4. Fluri F, Schuhmann MK, Kleinschnitz C – Animal models of ischemic stroke and their application in clinical research. Drug Des. Devel. Ther. 2015; 9:3445-3454]Search in Google Scholar
[5. Fuhrer H, Günther A, Zinke J – Optimizing cardiac output to increase cerebral penumbral perfusion in large middle cerebral artery ischemic lesion-OPTIMAL study. Front Neurol. 2017; 8:40210.3389/fneur.2017.00402555412728848494]Search in Google Scholar
[6. Rasouli J, Lekhraj R, Ozbalik M, Lalezari P, Casper D – Brain-spleen inflammatory coupling: a literature review. Einstein J Biol Med. 2011; 27(2):74-77]Search in Google Scholar
[7. Courties G, Herisson F, Sager HB, Heidt T, Ye Y, Wei Y, et al – Ischemic stroke activates hematopoietic bone marrow cells. Circ Res. 2015 Jan;116(3):407-1710.1161/CIRCRESAHA.116.305207431251125362208]Search in Google Scholar
[8. Schwartz-Bloom RD, Sah R – gamma-Aminobutyric acid(A) neurotransmission and cerebral ischemia. J Neurochem. 2001; 77(2):353-71]Search in Google Scholar
[9. Mele M, Costa RO, Duarte CB – Alterations in GABAA-Receptor Trafficking and Synaptic Dysfunction in Brain Disorders. Front Cell Neurosci. 2019; 13:7710.3389/fncel.2019.00077641622330899215]Search in Google Scholar
[10. Gelderblom M, Leypoldt F, Steinbach K, et al. – Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009; 40(5):1849-185710.1161/STROKEAHA.108.53450319265055]Search in Google Scholar
[11. Jin R, Yang G, Li G – Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol. 2010; 87(5):779-78910.1189/jlb.1109766285867420130219]Search in Google Scholar
[12. Liu ZJ, Chen C, Li FW, et al – Splenic response in ischemic stroke: new insights into stroke pathology. CNS Neurosci Ther. 2015; 21(4):320-32610.1111/cns.12361649527925475834]Search in Google Scholar
[13. Kim E, Yang J, Beltran CD, Cho S – Role of spleen-derived monocytes/macrophages in acute ischemic brain injury. J Cereb Blood Flow Metab. 2014; 34:1411–141910.1038/jcbfm.2014.101412608724865998]Search in Google Scholar
[14. Yan FL, Zhang JH – Role of the Sympathetic Nervous System and Spleen in Experimental Stroke-Induced Immunodepression. Med Sci Monit. 2014; 20:2489-249610.12659/MSM.890844426062025434807]Search in Google Scholar
[15. Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA, Hurn PD – Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab. 2006; 26(5):654-6510.1038/sj.jcbfm.960021716121126]Search in Google Scholar
[16. Amantea D, Certo M, Petrelli F, Bagetta G –Neuroprotective Properties of Macrolide Antibiotic in Mouse Model of Middle Cerebral Artery Occlusion: Characterization of the Immunomodulatory Effects and Validation of the Efficacy of Intravenous Administration. Assay Drug Dev Technol. 2016 ;14(5):298-30710.1089/adt.2016.728496049427392039]Search in Google Scholar
[17. Certo M, Endo Y, Ohta K, Sakurada S, Bagetta G, Amantea D – Activation of RXR/PPAR gamma underlines neuroprotection by bexarotene in ischemic stroke. Pharmacol Res. 2015; 102:298-30710.1016/j.phrs.2015.10.00926546745]Search in Google Scholar
[18. Seifert HA, Hall AA, Chapman CB, Collier LA, Willing AE, Pennypacker KR – A transient decrease in spleen size following stroke corresponds to splenocyte release into systemic circulation. J Neuroimmune Pharmacol. 2012; 7(4):1017–102410.1007/s11481-012-9406-8351857723054371]Search in Google Scholar
[19. Li P, Gan Y, Sun BL, Zhang F, Lu B, Gao Y, et al. Adoptive regulatory T-cell therapy protects against cerebral ischemia. Annals of neurology. 2013;74(3):458–7110.1002/ana.23815374816523674483]Search in Google Scholar
[20. Noble BT, Brennan FH, Popovich PG – The spleen as a neuroimmune interface after spinal cord injury. J. Neuroimmunol. 2018; 321:1–1110.1016/j.jneuroim.2018.05.00729957379]Search in Google Scholar
[21. Cesta MF – Normal structure, function, and Histology of the spleen. Toxicol Pathol. 2006; 34:455-46510.1080/0192623060086774317067939]Search in Google Scholar
[22. Steiniger BS – Human spleen microanatomy: why mice do not suffice. Immunology 2015; 145: 334–34610.1111/imm.12469447953325827019]Search in Google Scholar
[23. Vahidy FS, Parsha KN, Rahbar MH, et al. – Acute splenic responses in patients with ischemic stroke and intracerebral hemorrhage. J Cereb Blood Flow Metab. 2016; 36(6):1012-102110.1177/0271678X15607880490862026661179]Search in Google Scholar
[24. Pennypacker KR, Offner H – The role of the spleen in ischemic stroke. J Cereb Blood Flow Metab. 2015; 35(2):186-710.1038/jcbfm.2014.212442675425465042]Search in Google Scholar
[25. Okuaki Y, Miyazaki H, Zeniya M, et al. – Splenectomy-reduced hepatic injury induced by ischemia/reperfusion in the rat. Liver. 1996; 16(3):188-19410.1111/j.1600-0676.1996.tb00726.x]Search in Google Scholar
[26. Savas MC, Ozguner M, Ozguner IF, Delibas N – Splenectomy attenuates intestinal ischemia-reperfusion-induced acute lung injury. J Pediatr Surg. 2003; 38(10):1465-147010.1016/S0022-3468(03)00497-4]Search in Google Scholar
[27. Leuschner F, Panizzi P, Chico-Calero I, et al – Angiotensin-converting enzyme inhibition prevents the release of monocytes from their splenic reservoir in mice with myocardial infarction. Circ Res. 2010;107(11):1364-137310.1161/CIRCRESAHA.110.227454299210420930148]Search in Google Scholar
[28. Hurn PD, Subramanian S, Parker SM, – T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. J Cereb Bood Flow Metab. 2007; 27(11):1798-180510.1038/sj.jcbfm.9600482259268917392692]Search in Google Scholar
[29. Offner H, Subramanian S, Parker SM, et al. – Splenic atrophy in experimental stroke is accompanied by increased regulatory T Cells and circulating macrophages. J Immunol. 2006; 176:6523-653110.4049/jimmunol.176.11.652316709809]Search in Google Scholar
[30. Kriz J – 2006. Inflammation in ischemic brain injury: timing is important. Crit. Rev. Neurobiol. 2006; 18(1-2):145-15710.1615/CritRevNeurobiol.v18.i1-2.15017725517]Search in Google Scholar
[31. Ceulemans AG, Zgavc T, Kooijman R, Hachimi-Idrissi S, Sarre S, Michotte Y – The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia. J Neuroinflammation. 2010; 1(7):74]Search in Google Scholar
[32. Jickling GC, Liu D, Ander BP, Stamova B, Zhan X, Sharp FR. Targeting neutrophils in ischemic stroke: translational insights from experimental studies. J Cereb Blood Flow Metab. 2015 Jun;35(6):888-90110.1038/jcbfm.2015.45464025525806703]Search in Google Scholar
[33. Justicia C, Panes J, Sole S, Cervera A, Deulofeu R, Chamorro A, Planas AM. Neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlusion/reperfusion of the middle cerebral artery in rats. J Cereb Blood Flow Metab. 2003; 23: 1430–144010.1097/01.WCB.0000090680.07515.C814663338]Search in Google Scholar
[34. Rivera S, Ogier C, Jourquin J, Timsit S, Szklarczyk AW, Miller K, Gearing AJ, Kaczmarek L, Khrestchatisky M. Gelatinase B and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia. Eur J Neurosci. 2002; 15: 19–3210.1046/j.0953-816x.2001.01838.x11860503]Search in Google Scholar
[35. Montaner J, Alvarez-Sabin J, Molina C, Angles A, Abilleira S, Arenillas J, Gonzalez MA, Monasterio J. Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke. 2001; 32: 1759–176610.1161/01.STR.32.8.175911486102]Search in Google Scholar
[36. Rosell A, Ortega-Aznar A, Alvarez-Sabin, J, et al. – Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke. Stroke 2006; 37:1399-140610.1161/01.STR.0000223001.06264.af]Search in Google Scholar
[37. Yang Y, Rosenberg GA – Matrix metalloproteinases as therapeutic targets for stroke. Brain Res. 2015; 1623:30-3810.1016/j.brainres.2015.04.024]Search in Google Scholar
[38. Ajmo CT Jr, Collier LA, Leonardo CC et al. Blockade of adrenoreceptors inhibits the splenic response to stroke. Exp Neurol. 2009;218(1):47–5510.1016/j.expneurol.2009.03.044]Search in Google Scholar
[39. Zhang HT, Zhang P, Gao Y, et al. – Early VEGF inhibition attenuates blood-brain barrier disruption in ischemic rat brains by regulating the expression of MMPs. Mol. Med. Rep. 2017; 15:57-64]Search in Google Scholar
[40. Woodruff TM, Thundyil J, Tang SC, Sobey CG, Taylor SM, Arumugam TV – Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Mol Neurodegener. 2011; 6(1):1110.1186/1750-1326-6-11]Search in Google Scholar
[41. Yilmaz G, Arumugam T V, Stokes K Y, Granger D N. Role of T lymphocytes and interferon-γ in ischemic stroke. Circulation. 2006; 113:2105–2112.10.1161/CIRCULATIONAHA.105.593046]Search in Google Scholar
[42. Hurn P D, Subramanian S, Parker S M, Afentoulis M E, Kaler L J, Vandenbark A A, Offner H. T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. J Cereb Blood Flow Metab. 2007; 27:1798–180510.1038/sj.jcbfm.9600482]Search in Google Scholar
[43. Prass K, Meisel C, Höflich C Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation.J Exp Med. 2003 Sep 1;198(5):725-3610.1084/jem.20021098]Search in Google Scholar
[44. Shi K, Wood K, Shi FD, Wang X, Liu Q. Stroke-induced immunosuppression and poststroke infection.Stroke Vasc Neurol. 2018 Jan 12;3(1):34-41.10.1136/svn-2017-000123]Search in Google Scholar
[45. Arumugam T V, Granger D N, Mattson M P. Stroke and T-cells. Neuromolecular Med. 2005; 7:229–242.10.1385/NMM:7:3:229]Search in Google Scholar
[46. Dotson AL, Zhu W, Libal N, Alkayed NJ, Offner H. Different immunological mechanisms govern protection from experimental stroke in young and older mice with recombinant TCR ligand therapy. Front Cell Neurosci. 2014; 8:284.10.3389/fncel.2014.00284417476825309326]Search in Google Scholar
[47. Planas AM, Gómez-Choco M, Urra X, Gorina R, Caballero M, Chamorro Á – Brain-derived antigens in lymphoid tissue of patients with acute stroke. J Immunol. 2012; 188:2156-216310.4049/jimmunol.110228922287710]Search in Google Scholar
[48. Li P, Gan Y, Sun BL, Zhang F, Lu B, Gao Y, et al. Adoptive regulatory T-cell therapy protects against cerebral ischemia. Annals of neurology. 2013;74(3):458–71.10.1002/ana.23815374816523674483]Search in Google Scholar
[49. Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, Rivest S, et al. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med. 2009;15(2):192–19910.1038/nm.192719169263]Search in Google Scholar
[50. Kleinschnitz C, Kraft P, Dreykluft A, et al. Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. Blood. 2013;121(4):679–691.10.1182/blood-2012-04-426734379094723160472]Search in Google Scholar
[51. Xia Y, Cai W, Thomson AW, Hu X. Regulatory T Cell Therapy for Ischemic Stroke: how far from Clinical Translation? Transl Stroke Res. 2016;7(5):415-9]Search in Google Scholar
[52. Offner H, Subramanian S, Parker SM, et al. – Splenic atrophy in experimental stroke is accompanied by increased regulatory T Cells and circulating macrophages. J Immunol. 2006; 176:6523-653110.4049/jimmunol.176.11.652316709809]Search in Google Scholar
[53. Shichita T, Sugiyama Y, Ooboshi H, Sugimori H, Nakagawa R, Takada I, Iwaki T, Okada Y, Iida M, Cua D J, Iwakura Y, Yoshimura A. Pivotal role of cerebral interleukin-17-producing γδT cells in the delayed phase of ischemic brain injury. Nat Med. 2009; 15:946–95010.1038/nm.199919648929]Search in Google Scholar
[54. Chen C, Jiang W, Liu Z, et al. – Splenic responses play an important role in remote ischemic preconditioning-mediated neuroprotection against stroke. J Neuroinflammation. 2018;15(1):16710.1186/s12974-018-1190-9597244829807548]Search in Google Scholar
[55. Rehg JE, Bush D, Ward M – The utility of immunohistochemistry for the identification of hematopoietic and lymphoid cells in normal tissue and interpretation of proliferative and inflammatory lesions of mice and rats. Toxicologic Pathology 2012; 40:345-37410.1177/019262331143069522434870]Search in Google Scholar
[56. Chen Y, Bodhankar S, Murphy SJ, Vandenbark AA, Alkayed NJ, Offner H. Intrastriatal B-cell administration limits infarct size after stroke in B-cell deficient mice. Metab Brain Dis. 2012; 27:487–49310.1007/s11011-012-9317-7342771522618587]Search in Google Scholar
[57. Offner H, Hurn PD. A novel hypothesis: regulatory B lymphocytes shape outcome from experimental stroke. Transl Stroke Res. 2012; 3:324–33010.1007/s12975-012-0187-4350127223175646]Search in Google Scholar
[58. Schuhmann MK, Langhauser F, Kraft P, Kleinschnitz C – B cells do not have a major pathophysiologic role in acute ischemic stroke in mice. J Neuroinflammation. 2017; 14:11210.1186/s12974-017-0890-x545773328576128]Search in Google Scholar
[59. Doyle KP, Quach LN, Solé M, et al. – B-lymphocyte-mediated delayed cognitive impairment following stroke. J Neurosci 2015; 35(5):2133-214510.1523/JNEUROSCI.4098-14.2015431583825653369]Search in Google Scholar
[60. Bodhankar S, Chen Y, Vandenbark AA, Murphy SJ, Offner H – Treatment of experimental stroke with IL-10-producing B-cells reduces infarct size and peripheral and CNS inflammation in wild-type B-cell-sufficient mice Metab Brain Dis. 2014; 29(1):59-7310.1007/s11011-013-9474-3394405524374817]Search in Google Scholar
[61. Seifert HA, Leonardo CC, Hall AA et al. –The spleen contributes to stroke induced neurodegeneration through interferon gammasignaling. Metab Brain Dis. 2012; 27(2):131-141.10.1007/s11011-012-9283-0473973622354752]Search in Google Scholar
[62. Jayaraj RL, Azimullah S, Beiram R, Jalal FY, Rosenberg GA – Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflammation. 2019;16(1):14210.1186/s12974-019-1516-2661768431291966]Search in Google Scholar
[63. Amantea D. Polarizing the immune system towards neuroprotection in brain ischemia. Neural Regen Res (2016); 11(1):81-8210.4103/1673-5374.169633477423726981089]Search in Google Scholar
[64. Bao Y, Kim E, Bhosle S, Mehta H, Cho S – A role for spleen monocytes in post-ischemic brain inflammation and injury. J Neuroinflammation. 2010; 7:9210.1186/1742-2094-7-92301627321159187]Search in Google Scholar
[65. Fumagalli S, Perego C, Pischiutta F, Zanier ER, De Simoni MG – The ischemic environment drives microglia and macrophage function. Front Neurol. 2015; 6: e8110.3389/fneur.2015.00081438940425904895]Search in Google Scholar
[66. Kawabori M., Kacimi R., Kauppinen T., Calosing C., Kim J.Y., Hsieh C.L., Nakamura M.C., Yenari M.A. Ttriggering receptor expressed on myeloid cells 2 (TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke. J. Neurosci. 2015; 35:3384–339610.1523/JNEUROSCI.2620-14.2015433935125716838]Search in Google Scholar
[67. Nakagawa Y, Chiba K. – Role of microglial M1/M2 polarisation in relapse and remission of psychiatric disorders and diseases. Pharmaceuticals (Basel) 2014; 7(12): 1028-104810.3390/ph7121028427690525429645]Search in Google Scholar
[68. Chiba, T, Umegaki, K –2013. Pivotal Roles of Monocytes/Macrophages in Stroke. Mediators Inflamm. 2013, 75910310.1155/2013/759103356888923431245]Search in Google Scholar
[69. Kanazawa, M., Ninomiya, I., Hatakeyama, M., Takahashi, T., Shimohata, T., 2017. Microglia and monocytes/macrophages polarization reveal novel therapeutic mechanism against stroke. Int J Mol Sci.18(10), E 213510.3390/ijms18102135566681729027964]Search in Google Scholar
[70. Horváth E, Huțanu A, Chiriac L, Dobreanu M, Orãdan A, Nagy EE – Ischemic damage and early inflammatory infiltration are different in the core and penumbra lesions of rat brain after transient focal cerebral ischemia. J Neuroimmunol. 2018; 324:35-4210.1016/j.jneuroim.2018.08.00230212790]Search in Google Scholar